← Leaderboards
Edward H. Koo
University Of California San Diego
$17,601,880
Attributed
$20,064,735
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$33,270,476 · 13
By mechanism
P01$15,208,344 · 4
T32$9,523,949 · 2
R01$7,449,475 · 4
P50$1,020,515 · 2
K04$68,193 · 1
Top collaborators
- Stefan Leutgeb5 shared
- James B Brewer4 shared
- Todd E. Golde1 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Sonya Norman$1,243,833
- Laura S Redwine$5,363,609
- Elizabeth L Barrett-Connor$23,063,939
- Dongbao Chen$10,690,946
- Don W. Cleveland$43,935,794
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainTrainingAmyloid Beta-ProteinPathologyAmyloid Beta-Protein PrecursorAmyloidIn VivoHippocampus (Brain)Amyloid DepositionAmyloid ProteinsInsightToxic EffectLaboratoriesNeuronsSynaptic TransmissionSynapsesPathway InteractionsMediatingSynaptic FunctionEventProductionAging
Grant awards (64)
Multidisciplinary training in basic and translational Alzheimer's disease research$517,399
T32 · FY2023 · AG · contact PI
Multidisciplinary training in basic and translational Alzheimer's disease research$507,545
T32 · FY2022 · AG · contact PI
Multidisciplinary training in basic and translational Alzheimer's disease research$479,043
T32 · FY2021 · AG · contact PI
Multidisciplinary training in basic and translational Alzheimer's disease research$238,465
T32 · FY2020 · AG · contact PI
Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry$530,145
R01 · FY2018 · NS · contact PI
Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry$530,145
R01 · FY2017 · NS · contact PI
Training in the Neuroplasticity of Aging$5,213
T32 · FY2017 · AG · contact PI
Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry$530,145
R01 · FY2016 · NS · contact PI
Training in the Neuroplasticity of Aging$511,450
T32 · FY2016 · AG · contact PI
Training in the Neuroplasticity of Aging$643,958
T32 · FY2015 · AG · contact PI
Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry$530,088
R01 · FY2015 · NS · contact PI
Training in the Neuroplasticity of Aging$634,601
T32 · FY2014 · AG · contact PI
Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry$530,043
R01 · FY2014 · NS · contact PI
Cell-biological mechanisms underlying activity dependent Abeta generation$157,500
P50 · FY2014 · AG · contact PI
Novel Mechanisms of NSAID Action in Alzheimer's Disease$1,372,280
P01 · FY2013 · AG · contact PI
Training in the Neuroplasticity of Aging$556,306
T32 · FY2013 · AG · contact PI
CELLULAR MECHANISMS OF y-SECRETASE MODULATION AND EFFICACY OF COMBINATION TREATME$354,127
P01 · FY2013 · AG · contact PI
Novel Mechanisms of NSAID Action in Alzheimer's Disease$976,709
P01 · FY2012 · AG · contact PI
Training in the Neuroplasticity of Aging$623,773
T32 · FY2012 · AG · contact PI
CELLULAR MECHANISMS OF y-SECRETASE MODULATION AND EFFICACY OF COMBINATION TREATME$257,761
P01 · FY2012 · AG · contact PI
Novel Mechanisms of NSAID Action in Alzheimer's Disease$1,956,168
P01 · FY2011 · AG · contact PI
CELLULAR MECHANISMS OF y-SECRETASE MODULATION AND EFFICACY OF COMBINATION TREATME$526,567
P01 · FY2011 · AG · contact PI
Synaptic damage in models of beta-amyloid associated pathology$334,117
R01 · FY2011 · AG · contact PI
Training in the Neuroplasticity of Aging$247,238
T32 · FY2011 · AG · contact PI
Novel Mechanisms of NSAID Action in Alzheimer's Disease$1,529,185
P01 · FY2010 · AG · contact PI
Training in the Neuroplasticity of Aging$564,654
T32 · FY2010 · AG · contact PI
CELLULAR MECHANISMS OF y-SECRETASE MODULATION AND EFFICACY OF COMBINATION TREATME$394,669
P01 · FY2010 · AG · contact PI
Synaptic damage in models of beta-amyloid associated pathology$337,428
R01 · FY2010 · AG · contact PI
Novel Mechanisms of NSAID Action in Alzheimer's Disease$1,524,877
P01 · FY2009 · AG · contact PI
Training in the Neuroplasticity of Aging$560,325
T32 · FY2009 · AG · contact PI
CELLULAR MECHANISMS OF y-SECRETASE MODULATION AND EFFICACY OF COMBINATION TREATME$361,330
P01 · FY2009 · AG · contact PI
Synaptic damage in models of beta-amyloid associated pathology$330,962
R01 · FY2009 · AG · contact PI
Administrative Core$108,149
P01 · FY2009 · AG · contact PI
Training in the Neuroplasticity of Aging$556,035
T32 · FY2008 · AG · contact PI
Abeta42 Altering Compounds: Mechanisms of Action$532,692
R01 · FY2008 · AG
Synaptic damage in models of beta-amyloid associated pathology$321,324
R01 · FY2008 · AG · contact PI
ROLE OF APP AND INTERACTING PROTEINS IN SYNAPTIC DAMAGE$201,520
P50 · FY2008 · AG · contact PI
Training in the Neuroplasticity of Aging$556,035
T32 · FY2007 · AG · contact PI
APP Trafficking and the Pathways of A Beta Formation$342,957
R01 · FY2007 · AG · contact PI
Synaptic damage in models of beta-amyloid associated pathology$318,330
R01 · FY2007 · AG · contact PI
ROLE OF APP AND INTERACTING PROTEINS IN SYNAPTIC DAMAGE$205,523
P50 · FY2007 · AG · contact PI
Novel mechanisms of NSAID action in Alzheimer disease$1,262,697
P01 · FY2006 · AG · contact PI
Training in the Neuroplasticity of Aging$523,290
T32 · FY2006 · AG · contact PI
APP Trafficking and the Pathways of A Beta Formation$352,517
R01 · FY2006 · AG · contact PI
ROLE OF APP AND INTERACTING PROTEINS IN SYNAPTIC DAMAGE$154,273
P50 · FY2006 · AG · contact PI
Novel mechanisms of NSAID action in Alzheimer disease$1,255,421
P01 · FY2005 · AG
APP Trafficking and the Pathways of A Beta Formation$361,000
R01 · FY2005 · AG
Training in the Neuroplasticity of Aging$263,991
T32 · FY2005 · AG
ROLE OF APP AND INTERACTING PROTEINS IN SYNAPTIC DAMAGE$149,781
P50 · FY2005 · AG
Novel mechanisms of NSAID action in Alzheimer disease$1,182,362
P01 · FY2004 · AG
Training in the Neuroplasticity of Aging$529,030
T32 · FY2004 · AG
APP Trafficking and the Pathways of A Beta Formation$361,000
R01 · FY2004 · AG
ROLE OF APP AND INTERACTING PROTEINS IN SYNAPTIC DAMAGE$151,918
P50 · FY2004 · AG
Novel mechanisms of NSAID action in Alzheimer disease$1,014,675
P01 · FY2003 · AG
Training in the Neuroplasticity of Aging$515,007
T32 · FY2003 · AG
APP Trafficking and the Pathways of A Beta Formation$361,000
R01 · FY2003 · AG
Novel Mechanisms of NSAID Action in Alzheimer's Disease$133,247
P01 · FY2003 · AG
Novel mechanisms of NSAID action in Alzheimer disease$998,120
P01 · FY2002 · AG
Training in the Neuroplasticity of Aging$490,591
T32 · FY2002 · AG
APP TRAFFICKING AND THE PATHWAYS OF A BETA FORMATION$328,196
R01 · FY2002 · AG
CELLULAR MECHANISMS OF NSAID INDUCED A-BETA 42 REDUCTION$0
P01 · FY2002 · AG
APP TRAFFICKING AND THE PATHWAYS OF A BETA FORMATION$291,648
R01 · FY2001 · AG
APP TRAFFICKING AND THE PATHWAYS OF A BETA FORMATION$225,738
R01 · FY2000 · AG
APP INTERNALIZATION--PREREQUISITE FOR ABETA FORMATION?$68,193
K04 · FY2000 · NS